COVID-19

October 26, 2020

COVID treatment studied by VUMC gains FDA approval

Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.

By Bill Snyder
October 20, 2020

Ascension St. Thomas, Tristar Health, Meharry Medical College/Nashville General Hospital, Vanderbilt Health issue joint statement on COVID-19

The number of active COVID-19 cases in Tennessee is rising. In the 13 counties that comprise the Nashville Metropolitan Area, new cases have increased 50% over the last 2 weeks. We strongly urge everyone in Middle Tennessee, and all Tennesseans, to remain vigilant in their efforts to limit the spread of the virus by wearing masks, washing hands and staying socially distant — including not participating in large gatherings.

By VUMC News and Communications
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

By Bill Snyder
October 15, 2020

Possible COVID-19 “decoy”

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.

By Bill Snyder
Posing with the award presented by the Tennessee Hospital Association are (front row, from left) Molly Knostman, PharmD, MHA, C. Wright Pinson, MBA, MD, Patty Wright, MD, Mark Sullivan, PharmD (back row, from left) Halden Van Cleave, PharmD, MS, Deidra Dickerson, PharmD, Garrett Crothers, PharmD, Kevin Scharfman, PharmD, Eric Patton and Ryan Schell, PharmD.
October 14, 2020

THA honors VUMC efforts in remdesivir distribution

A team of pharmacists and physicians from Vanderbilt University Medical Center that this spring took on statewide distribution of remdesivir, an urgently needed investigational drug for severely ill patients hospitalized with COVID-19, has received the President’s Award from the Tennessee Hospital Association (THA).

By Bill Snyder
James Crowe Jr., MD, and colleagues are exploring how the body’s immune system gears up to fight off infection.
October 13, 2020

COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials

AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.

By Bill Snyder
October 8, 2020

Undiagnosed Diseases Network continues to excel despite pandemic

Though the COVID-19 pandemic halted in-person patient visits at Undiagnosed Diseases Network (UDN) sites, including Vanderbilt University Medical Center’s, since March, groundbreaking behind-the-scenes work continues.
By Nancy Humphrey
October 8, 2020

COVID patient’s heart-lung transplant is world’s first

Vanderbilt University Medical Center has performed the world’s first dual heart-lung transplant of a COVID-19 patient.
By Matt Batcheldor
October 7, 2020

StrategyShare2020 presents thought-provoking sessions

Although the global COVID-19 pandemic forced StrategyShare2020 organizers to rapidly transform the event to an online-only format, there were no compromises in the quality and depth of the presentations, and more than 1,000 individuals registered to participate interactively, a record number for the annual event.
By Jill Clendening
October 2, 2020

Video showcases notes of appreciation for VUMC COVID fighters

Words of encouragement and thanks have poured in from all over the U.S. and from other countries.
By Wayne Wood
October 1, 2020

Caregivers discuss impacts of treating COVID-19 patients

Taking care of patients critically ill with COVID-19 takes an emotional and physical toll on health care providers who say many of these patients are among the sickest they’ve ever encountered.
By Nancy Humphrey
September 24, 2020

Cancer centers nationwide join to address the impact of COVID-19 pandemic on cancer prevention and treatment

A consortium of 17 cancer centers in the United States, including Vanderbilt-Ingram Cancer Center, have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.
By VUMC News and Communications
September 24, 2020

REDCap helps state of Washington scale up its testing capacity

Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.
By Bill Snyder
1 … 19 20 21 22 23 … 39